Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Proton beam therapy
WHERE t1.sid in(parameter_dbtbl_keyword '%Proton beam therapy%') and t1.xml_status <> 99
1
results for
"Proton beam therapy"
Filter
Article category
Editorial (1)
Keywords
Carbon ion radiotherapy (1)
Hepatocellular carcinoma (1)
Proton beam therapy (1)
Radiotherapy (1)
Publication year
2023 (1)
Keywords
Carbon ion radiotherapy (1)
Hepatocellular carcinoma (1)
Proton beam therapy (1)
Radiotherapy (1)
Cancel
Close
Publication Year
2023 (1)
Cancel
Close
Funded articles
Cancel
Close
"Proton beam therapy"
Editorial
Hepatic neoplasm
Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
Sang Min Yoon
Clin Mol Hepatol
2023;29(4):977-979.
Published online August 31, 2023
DOI:
https://doi.org/10.3350/cmh.2023.0336
PDF
Citations
Citations to this article as recorded by
Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma
Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi
Clinical and Molecular Hepatology
.2026; 32(1): e38.
CrossRef
Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
Journal of Ethnopharmacology
.2025; 336: 118706.
CrossRef
Intelligent Hydrogel-Assisted Hepatocellular Carcinoma Therapy
Zixiang Tang, Lin Deng, Jing Zhang, Tao Jiang, Honglin Xiang, Yanyang Chen, Huzhe Liu, Zhengwei Cai, Wenguo Cui, Yongfu Xiong
Research
.2024;[Epub]
CrossRef
6,357
View
52
Download
3
Web of Science
3
Crossref
First
Prev
Page
of 1
Next
Last
×
TOP
First
Prev
